Crossmark

Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis

Crossref DOI link: https://doi.org/10.1186/s12885-018-4696-8

Published Online: 2018-08-09

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bettinger, Dominik https://orcid.org/0000-0002-8782-8729
Gkika, Eleni

Schultheiss, Michael

Glaser, Nicolas

Lange, Sophie

Maruschke, Lars

Buettner, Nico

Kirste, Simon

Nestle, Ursula

Grosu, Anca-Ligia

Thimme, Robert

Brunner, Thomas B.
Funding

Funding for this research was provided by:

Berta-Ottenstein Programme
License Information

Text and Data Mining valid from 2018-08-09
More Information

Article History

Received: 12 March 2018

Accepted: 26 July 2018

First Online: 9 August 2018

Ethics approval and consent to participate

: All patients provided written inform consent for TACE or SBRT and for data collection. This study was performed in accordance with the Declaration of Helsinki and it has been approved by the local ethics committee of the University Hospital of Freiburg (no. EK 62/14 and no. EK 350/16).

: Not applicable.

: DB receives teaching and speaking fees from Bayer Healthcare.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.